Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)

Lignende værker

• Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)
  af: Yuantai Li, et al.
  Udgivet: (2025-09-01)
• Association of basal thyroid function with clinical outcomes in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-L1 inhibitor KL-A167: a multicenter post hoc analysis
  af: Keliang Chen, et al.
  Udgivet: (2026-04-01)
• Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
  af: Li H, et al.
  Udgivet: (2026-06-01)
• Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors
  af: Jianming Diao, et al.
  Udgivet: (2025-03-01)
• Metastatic nasopharyngeal carcinoma: Outcome from Cancer Institute, Chennai
  af: Arun Kumar, et al.
  Udgivet: (2020-01-01)